Birdwatch Note
2022-12-18 22:52:37 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
While the study did observe an increase in cerebral clots from COVID-19 vaccines, it was lower than the clotting from actual infection. The other study supporting that conclusion is preprint and found the relative risk of infection was as little as 1.5 to 4 (lower end of CI) https://www.ox.ac.uk/news/2021-04-15-risk-rare-blood-clotting-higher-covid-19-vaccines
Written by E7A1E1FAD38712BEEB291561B0D38E0D2FE5D0BFCF716CCAFBC7A0FD42949336
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1604247306034978818
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1604610613971681280
- noteId - 1604610613971681280
- participantId - E7A1E1FAD38712BEEB291561B0D38E0D2FE5D0BFCF716CCAFBC7A0FD42949336
- noteAuthorParticipantId -
- createdAtMillis - 1671403957251
- tweetId - 1604247306034978818
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- While the study did observe an increase in cerebral clots from COVID-19 vaccines, it was lower than the clotting from actual infection. The other study supporting that conclusion is preprint and found the relative risk of infection was as little as 1.5 to 4 (lower end of CI) https://www.ox.ac.uk/news/2021-04-15-risk-rare-blood-clotting-higher-covid-19-vaccines
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2022-12-18 22:52:37 UTC (1671403957251) |
1969-12-31 23:59:59 UTC (-1) |
2022-12-19 02:11:15 UTC (1671415875434) |
1969-12-31 23:59:59 UTC (-1) |
E7A1E1FAD38712BEEB291561B0D38E0D2FE5D0BFCF716CCAFBC7A0FD42949336 |
Note Ratings
rated at | rated by | |
2022-12-18 21:20:12 -0600 | 004C4131B6547F5B1D952B9ECA4A4EA3795D278962FB5ABE92972609BD93DF52 | Rating Details |
2022-12-19 04:10:19 -0600 | 050FCFBE29BDDA47E8F721074005460527A5FD69ADDDF0C19D0253327788E9BB | Rating Details |
2022-12-19 21:08:34 -0600 | 08BBEC117D2192658FE49EFBABE6C665D5AAEB8C7ACF59A955CA8AB69CDC2583 | Rating Details |
2022-12-18 22:07:55 -0600 | 162C4A5824F88C80FBC6DCA63E8F4243764C8C30B211DF4B22DE6B2844650D48 | Rating Details |
2022-12-18 17:02:58 -0600 | 1FF7561FE0126E6B8A5D839EB3A16092850E5849FCEFA315CBFDDE0A2A95FFF6 | Rating Details |
2022-12-19 23:35:11 -0600 | 2A6CB26D268828D7DAB1C53D580289ED5183AC07092D5C6EDAC14009E74D529F | Rating Details |
2022-12-19 03:53:31 -0600 | 31F053B86F3733D0D810620D4417F2EC823D3BCF01C95FE0290EBC1EEB35216F | Rating Details |
2022-12-19 21:38:33 -0600 | 32A2A67AD9632BEEC26D25D7C0FCA8FCE8C5992C1EC5CDB84D36607F94384452 | Rating Details |
2022-12-20 11:18:37 -0600 | 38F3548DB0968885447F4DB82116D4277DCAC84BCA00434FF4A2AF27332D007E | Rating Details |
2022-12-19 21:05:12 -0600 | 3982F8334973284B3D45162CD75A5249ECF31B8303D9B71E94DE95D704D139BA | Rating Details |
2022-12-20 01:06:45 -0600 | 461598DDA4A95E8493FA4884FF45B1730836E301BB98475B6F97BBD3AF806DD7 | Rating Details |
2023-01-17 11:35:35 -0600 | 4960ACBCBA41AFD466E08606DFC0841AFDCAFD636B55C7AEC47B692BC3A5A61B | Rating Details |
2022-12-19 01:36:33 -0600 | 4B17FFAA00CF2918BF17001238225FDC8CCB8EBCF1720CDC9EE921C60291815E | Rating Details |
2022-12-19 22:59:28 -0600 | 4B23E48D9540C7D1D005645BA9BA852FAFD608D180BEAEB07035FE5626EE5EE5 | Rating Details |
2022-12-19 02:33:59 -0600 | 53A5BD47B7CF5688A8FEE9AA268D5C0A87F3DD1B45D40D220B8D093D2880A498 | Rating Details |
2022-12-29 01:46:48 -0600 | 547B46B38A1CB3060240F9F561852ADB212E08AA27CDAE1D9BE8DDCD9A5D2518 | Rating Details |
2022-12-19 22:34:29 -0600 | 5F17C41B1D90A9479B47982F377D3353EFC563FE471634BFDB4FDC72A6A0EFDE | Rating Details |
2022-12-19 21:02:52 -0600 | 7086892CD195477217621A5E886859CBDCF1BA440A87FB738C21A3453E2538CE | Rating Details |
2022-12-18 19:23:21 -0600 | 7300E9627B289D8587C36C3B28CA9A3820AD2F038CA68DC1F3B959B70C3F6E66 | Rating Details |
2022-12-19 22:33:58 -0600 | 73CA3F91B9E69AA685CFE20AEC1DE24C1A7084F914BAD6193CB50CEB6589A074 | Rating Details |
2022-12-19 22:53:10 -0600 | 73E313E3E609BD537C9910C991280EDCD0E5E365544A8DE15F4C16E6D7B722E5 | Rating Details |
2022-12-18 17:17:28 -0600 | 78AD503BD053AAD6EBAC3746EA58B4A59B488957DD5769AFD7196037F29E8398 | Rating Details |
2022-12-18 21:33:41 -0600 | 7B0BF9EA088CF6B749983E62A0CEB5F7C2AE179A598117E9C1578867EA130B88 | Rating Details |
2022-12-18 20:34:17 -0600 | 86ECE69C940A2C7CD624A88CA206174EE55AA6594DB09817A23512D053A8BE38 | Rating Details |
2022-12-20 07:24:41 -0600 | 87E61863523BE76EB09FBA366A02460B40A099D6B5CC44CC1549E0BE07375259 | Rating Details |
2022-12-19 21:17:17 -0600 | 8AFA4729C615E402C1076187A2B95EE3714CC1ECEE9E372CA5A40E30E620DCF4 | Rating Details |
2022-12-19 12:58:09 -0600 | 8E2BA73E12AF4C501F07CFC148A27544B50BF2C5005A428C1CF40AA738BFE37A | Rating Details |
2022-12-28 12:01:08 -0600 | 96259C16C38458FE7A8A6C293A8049357F7D3EC2D0F557E58FD8034ED6400C1F | Rating Details |
2022-12-19 21:06:29 -0600 | 9AA87F370C6B325587ABE9DF5C329AFBF5C2D506A8753E2D225EBCA6B49919AF | Rating Details |
2022-12-20 00:07:31 -0600 | A309DB468B10766A8BFB655E0D6FC3D19E69FD7887182F5282108284DA8F7C38 | Rating Details |
2022-12-21 16:11:45 -0600 | A47E4814DE74918B0AB90BE8092C6A1FCA60BD9A690DE7AF6D29035CC4E1BFDB | Rating Details |
2022-12-20 09:00:16 -0600 | BE330D9D7E5597F4AD7FF551186734C7D40813FA163D12C04FA776B26A1613FE | Rating Details |
2022-12-19 21:42:27 -0600 | C9BAC9DFCC37BD995E45586D6F1DE5B263C891E2ED3122014B3431F8F85E4D89 | Rating Details |
2022-12-18 23:02:01 -0600 | CE1E67B1FEB9937B7C6D47043A93A78DEDF0B169BBA3B6DFC46DF275D11557E3 | Rating Details |
2022-12-20 06:50:14 -0600 | CFB9229A27CE68851D3820AC6CA175846CA764232C7293FB583812FD1CFEA61F | Rating Details |
2022-12-18 17:23:08 -0600 | D2B41DE7C771F03302E3AFF4CB1FC4602AC502AC0C353D1BBC16B922D23BC41D | Rating Details |
2022-12-19 01:18:04 -0600 | D8B7DEE54D9DB27DBBA10B53B035C4B7BE1E605DBA403FE18026C5747F32693B | Rating Details |
2022-12-19 23:55:48 -0600 | DA788CB85955C52E4759E096FE03AE43CF66927F983672722660B83D07827E8C | Rating Details |
2022-12-19 13:53:22 -0600 | E1D424D88A66C7631CCF808F27987D286E32CED22CDF9AEAA5D4A48BBA5F9A10 | Rating Details |
2022-12-19 23:43:54 -0600 | EB26135AA25EC18D5C1DC9B32A8DEAEF3B47F23E0D61425499DD3EF4EBD0E5EC | Rating Details |
2022-12-18 17:22:09 -0600 | FB734FAB1773B65ABC7F78CBB460EFCD0411A464C68542588BE9DB3E2550FE06 | Rating Details |
2022-12-19 22:44:58 -0600 | FBD405E0A052BE2F1C343939A835034F8B4CF724F7503F72F4F099E82E21CD36 | Rating Details |
2022-12-20 11:21:41 -0600 | FC14E6E7ADF494F6833E2F41E318F8323B9E0E34B345C479574F4DEF12AF1C65 | Rating Details |
2022-12-18 22:07:55 -0600 | Rating Details | |
2022-12-19 22:44:58 -0600 | Rating Details | |
2022-12-19 12:58:09 -0600 | Rating Details | |
2022-12-19 03:53:31 -0600 | Rating Details | |
2022-12-18 17:23:08 -0600 | Rating Details | |
2022-12-19 21:05:12 -0600 | Rating Details | |
2022-12-21 16:11:45 -0600 | Rating Details | |
2023-01-17 11:35:35 -0600 | Rating Details | |
2022-12-18 17:17:28 -0600 | Rating Details | |
2022-12-19 21:08:34 -0600 | Rating Details | |
2022-12-19 23:43:54 -0600 | Rating Details | |
2022-12-19 01:18:04 -0600 | Rating Details | |
2022-12-18 20:34:17 -0600 | Rating Details | |
2022-12-19 01:36:33 -0600 | Rating Details | |
2022-12-19 22:59:28 -0600 | Rating Details | |
2022-12-18 23:02:01 -0600 | Rating Details | |
2022-12-19 21:42:27 -0600 | Rating Details | |
2022-12-19 23:55:48 -0600 | Rating Details | |
2022-12-28 12:01:08 -0600 | Rating Details | |
2022-12-19 21:02:52 -0600 | Rating Details | |
2022-12-20 07:24:41 -0600 | Rating Details | |
2022-12-19 22:34:29 -0600 | Rating Details | |
2022-12-18 19:23:21 -0600 | Rating Details | |
2022-12-20 11:18:37 -0600 | Rating Details | |
2022-12-19 04:10:19 -0600 | Rating Details | |
2022-12-19 21:38:33 -0600 | Rating Details | |
2022-12-20 11:21:41 -0600 | Rating Details | |
2022-12-19 21:06:29 -0600 | Rating Details | |
2022-12-18 17:02:58 -0600 | Rating Details | |
2022-12-19 23:35:11 -0600 | Rating Details | |
2022-12-19 13:53:22 -0600 | Rating Details | |
2022-12-18 21:33:41 -0600 | Rating Details | |
2022-12-20 00:07:31 -0600 | Rating Details | |
2022-12-18 17:22:09 -0600 | Rating Details | |
2022-12-29 01:46:48 -0600 | Rating Details | |
2022-12-20 01:06:45 -0600 | Rating Details | |
2022-12-20 09:00:16 -0600 | Rating Details | |
2022-12-19 21:17:17 -0600 | Rating Details | |
2022-12-20 06:50:14 -0600 | Rating Details | |
2022-12-19 22:53:10 -0600 | Rating Details | |
2022-12-18 21:20:12 -0600 | Rating Details | |
2022-12-19 02:33:59 -0600 | Rating Details | |
2022-12-19 22:33:58 -0600 | Rating Details |